International Emerging Markets - Regulation at the Jurisdictional Level

Jason Moscovici Related Seminars and Products

Founder | President

Provisions Legal Services Inc.

Jason Moscovici is a lawyer, biochemist, and founder of Provisions Legal Services, a Canadian law firm specialized in regulated industries. His practice focuses on intellectual property and regulatory compliance in fields such as cannabis, pharmaceuticals, medical devices, cosmetics, personal care products, nicotine delivery and natural health products.

Jason’s focus on the valorization and enforcement of IP, as well as the numerous compliance issues that orbit regulated businesses, have allowed him to become one of the most trusted legal advisors to the emerging international cannabis industry. His perspectives on innovation, and the commercial hurdles related specifically to the area of controlled substances old and new, are routinely solicited by industry groups and other stakeholders in this space. He sits on several committees and working groups dedicated to identifying and establishing international legal practices in these areas.

Marie Sanchez Related Seminars and Products

Lawyer & Founder

Nooa Avocats

Marie Sanchez is a lawyer at the Bars of Paris and Quebec. After beginning her career in Singapore with a large pharmaceutical group, she worked for nearly 10 years in renowned international law firms before founding NOOA Avocats.

A specialist in regulatory and contractual aspects related to life sciences, she has also developed expertise in the field of therapeutic cannabis and well-being hemp. She regularly intervenes in the context of training courses as well as in conferences, in France and abroad.

She holds a Master II Professional in Health Industry Law from the University of Montpellier I as well as an ESSEC-Mannheim Executive MBA.

Dr. Jayashree Mitra Related Seminars and Products

Shareholder

Carlton Fields, P.A.

Dr. Jayashree Mitra focuses on patent litigation, including Hatch-Waxman patent litigation. She represents clients in federal court and before the Patent Trial and Appeal Board and the International Trade Commission in a full range of patent litigation, including Hatch-Waxman actions, inter partes review, post-grant review proceedings, and trade secret disputes. She also advises clients in the cannabis industry and psychedelic industry on regulatory compliance, helping them align their IP strategies to comply with FDA and DEA regulations and guidance.

Jayashree is well known for her detailed understanding of the pharmaceutical, biotechnology, cannabis, psychedelics, and emerging technology sectors. A former neuropharmaceutical researcher at Yale University, Jayashree's technical knowledge extends to small molecules, protein therapeutics, protein conjugates, vaccines, injectables, biologics, and biosimilars, as well as blockchain and data privacy. She has particular insight into the science underlying innovative cannabis technology products and psychedelics. Her research in neuropharmacology at Yale specifically involved analyzing the effects of psychoactive substances on the developing brain.

She also has experience handling antitrust matters, as well as intellectual property due diligence and technology agreements for mergers, acquisitions, and other corporate transactions. She is recognized as a certified information privacy professional (CIPP/US) by the International Association of Privacy Professionals.

Jayashree engages in extensive pro bono work, including criminal appeals and death penalty cases.

Daniel Haymann, MBA Related Seminars and Products

Legal Counsel

MME Legal | Tax | Compliance

Daniel Haymann specializes in corporate and commercial law. Based on his extensive business experience, he has a good feel for new markets and understands the requirements of go-to-market and scale-up strategies. As an interdisciplinary and hands-on advisor, his focus is on investments, venture capital and financing transactions as well as regulatory issues in the healthcare and consumer goods sectors.

He advises investors, start-ups and vertically integrated companies along the value chain, including on regulatory issues relating to THC, CBD and other cannabinoids and psychoactive substances, GMP and GDP standards, food and cosmetics regulations and approval procedures before Swissmedic, the Swiss remedy institute.

Daniel is co-founder and co-chair of the European branch of the International Cannabis Bar Association (INCBA Europe). As a Swiss-Israeli dual citizen, he also focuses on serving clients with connections to Israel and strengthening the relevant business relationships.

Prior to his career as a lawyer, Daniel spent over 10 years in senior positions as a commodity trader for multinational corporations.